These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 17175244
1. Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis. Krebs R, Hollmén ME, Tikkanen JM, Wu Y, Hicklin DJ, Koskinen PK, Lemström KB. Transplant Proc; 2006 Dec; 38(10):3266-7. PubMed ID: 17175244 [Abstract] [Full Text] [Related]
2. Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. Krebs R, Tikkanen JM, Nykänen AI, Wood J, Jeltsch M, Ylä-Herttuala S, Koskinen PK, Lemström KB. Am J Respir Crit Care Med; 2005 Jun 15; 171(12):1421-9. PubMed ID: 15778488 [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection. Rintala SE, Savikko J, Rintala JM, von Willebrand E. Transplant Proc; 2006 Dec 15; 38(10):3236-8. PubMed ID: 17175233 [Abstract] [Full Text] [Related]
4. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton T, Shorthouse R, Huang X, Boname J, Girgis R, Raitz BA, Mocarski E, Sandford G, Morris RE. J Heart Lung Transplant; 1998 May 15; 17(5):439-51. PubMed ID: 9628562 [Abstract] [Full Text] [Related]
5. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. Kallio EA, Koskinen PK, Aavik E, Vaali K, Lemstöm KB. J Clin Invest; 1997 Dec 15; 100(12):2984-94. PubMed ID: 9399944 [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor in chronic rat allograft nephropathy. Malmström NK, Kallio EA, Rintala JM, Nykänen AI, Räisänen-Sokolowski AK, Paavonen T, Lemström KB, Koskinen PK. Transpl Immunol; 2008 May 15; 19(2):136-44. PubMed ID: 18503889 [Abstract] [Full Text] [Related]
7. Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease. Tikkanen JM, Hollmén M, Nykänen AI, Wood J, Koskinen PK, Lemström KB. Am J Respir Crit Care Med; 2006 Nov 15; 174(10):1145-52. PubMed ID: 16917119 [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS. Cancer Res; 2008 Jan 15; 68(2):521-9. PubMed ID: 18199548 [Abstract] [Full Text] [Related]
9. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection. Kuo E, Bharat A, Shih J, Street T, Norris J, Liu W, Parks W, Walter M, Patterson GA, Mohanakumar T. Ann Thorac Surg; 2006 Oct 15; 82(4):1226-33. PubMed ID: 16996912 [Abstract] [Full Text] [Related]
10. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Krebs R, Tikkanen JM, Ropponen JO, Jeltsch M, Jokinen JJ, Ylä-Herttuala S, Nykänen AI, Lemström KB. Am J Pathol; 2012 Nov 15; 181(5):1607-20. PubMed ID: 22959907 [Abstract] [Full Text] [Related]
12. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily]. Qi Z, Yang DY, Wang R, Wang SZ, Ping YM. Zhonghua Wai Ke Za Zhi; 2007 Feb 15; 45(4):262-6. PubMed ID: 17502025 [Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M. Mol Ther; 2004 Nov 15; 10(5):844-54. PubMed ID: 15509502 [Abstract] [Full Text] [Related]
16. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans. Watanabe T, Okada Y, Hoshikawa Y, Eba S, Notsuda H, Watanabe Y, Ohishi H, Sato Y, Kondo T. Transplant Proc; 2012 May 15; 44(4):1155-7. PubMed ID: 22564651 [Abstract] [Full Text] [Related]
17. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow. Fernández FG, McKane B, Marshbank S, Patterson GA, Mohanakumar T. J Heart Lung Transplant; 2005 Jul 15; 24(7 Suppl):S232-8. PubMed ID: 15993779 [Abstract] [Full Text] [Related]
18. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis. KleinJan A, Willart MA, Kuipers H, Coyle AJ, Hoogsteden HC, Lambrecht BN. Transplantation; 2008 Nov 27; 86(10):1436-44. PubMed ID: 19034015 [Abstract] [Full Text] [Related]
19. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis. Fan K, Qiao XW, Nie J, Yuan L, Guo HZ, Zheng ZK, Li JS, Wang JJ, Jiang K. Transpl Immunol; 2013 Jun 27; 28(4):170-5. PubMed ID: 23619376 [Abstract] [Full Text] [Related]
20. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S. Gastroenterology; 2009 Feb 27; 136(2):585-95.e5. PubMed ID: 19013462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]